AURA - Aura Biosciences, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$17.00
DETAILS
HIGH:
$17.00
LOW:
$17.00
MEDIAN:
$17.00
CONSENSUS:
$17.00
UPSIDE:
123.68%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 0.0% |
| EBIT Margin | 0.0% |
| EBITDA Margin | 0.0% |
| Operating Margin | 0.0% |
| Pretax Margin | 0.0% |
| Cont. Ops Margin | 0.0% |
| Net Margin | 0.0% |
| Bottom Line Margin | 0.0% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 8.15 |
| Quick Ratio | 8.15 |
| Solvency Ratio | -3.231 |
| Cash Ratio | 3.24 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-3.10
Peers avg: 0.3
|
| PEG Ratio | -5.42 |
| Forward PEG | -5.42 |
| Price/Book | 2.40 |
| Price/Sales | 0.00 |
| Price/FCF | -3.86 |
| Price/Op Cash Flow | -3.88 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.1026 |
| Debt/Equity | 0.1269 |
| Debt/Capital | 0.1126 |
| Long-Term Debt/Capital | 0.0936 |
| Financial Leverage | 1.24 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.00 |
| Operating Cash Flow Ratio | -4.610 |
| Operating Cash Flow/Sales | 0.0% |
| Free Cash Flow/Operating Cash Flow | 100.5% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -34.47 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | -26.13 |
| Operating Cash Flow Coverage | -4.88 |
| Capital Expenditure Coverage | -189.58 |
| Dividend + Capital Expenditure Coverage | -189.58 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.00 |
| EPS | -1.760 |
| Debt/Share | 0.2880 |
| Cash/Share | 2.39 |
| Book Value/Share | 2.27 |
| Tangible BV/Share | 2.27 |
| Equity/Share | 2.27 |
| Operating Cash Flow/Share | -1.404 |
| Capital Expenditure/Share | 0.007 |
| FCF/Share | -1.412 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.001 |
| Earnings Before Tax/EBIT | 0.941 |
| Price/Fair Value | 2.40 |
| Debt/Market Cap | 0.0528 |
| Effective Tax Rate | -0.1% |
| Enterprise Value Multiple | -2.57 |